60Nd

60Nd is a deep-tech spin-off from Universidad Carlos III de Madrid (UC3M) that bridges the gap between static in vitro models and the mechanical reality of living tissues. While traditional models lack the physical cues essential for accurate biological responses, 60Nd’s flagship platform, NeoMag, uses programmable magneto-active polymers (MAP) and AI to induce precise, non-invasive mechanical stimulation in 2D and 3D cell cultures.

Why it matters for Researchers & Pharma:

• Realistic Pathological Simulation: Reproduce the mechanical microenvironments of cancer, traumatic brain injury (TBI), and myocardial infarction directly in the lab.

• Unmatched Precision: Apply dynamic, reversible, and contact-free deformations—such as stretching, compression, and shear—to study mechanotransduction in real-time.

• Reduced Preclinical Failure: By incorporating mechanical variables early in drug discovery, NeoMag helps anticipate therapy failures and reduces reliance on animal testing.

• Seamless Integration: A plug-and-play, portable system compatible with standard live-imaging microscopy and advanced analytical tools like nanoindenters.

60Nd is currently collaborating with top-tier global labs (including UCSF, Imperial College London, and Johns Hopkins) to define the next standard for predictive biology and accelerate the development of mechanosensitive therapies.